Union Science and Technology Minister Dr. Jitendra Singh on Saturday, 28 June 2026 presented Awards of Excellence to distinguished medical professionals and delivered a keynote address at a Doctors Day Fireside Chat, outlining India's strategic vision for precision medicine, genomics, and AI-driven healthcare ahead of National Doctors Day on 1 July.

Context

Speaking at the conclave, Dr. Singh articulated a sweeping case for India-specific medical data, stating: 'India's vast genetic diversity, heterogeneous disease profile and rapidly expanding scientific capabilities offer an unprecedented opportunity to develop Indian data for Indian treatment for Indian patients, while contributing affordable and globally relevant healthcare solutions for the rest of the world as well.' The remarks position India not merely as a consumer of global biomedical research but as an originator of solutions suited to its own population — and exportable to others.

The minister framed precision medicine as the defining shift in modern healthcare: 'Precision Medicine and personalised healthcare will redefine the future of medical practice by enabling more accurate diagnosis, targeted therapies and improved patient outcomes.' He added that treatment would increasingly be 'tailored to an individual's genetic profile, lifestyle and environmental factors.'

Policy Backdrop

At the centre of Dr. Singh's address was the Genome India Mission, a Department of Biotechnology initiative formally launched in 2020 to build a national genomic reference database. The minister stated the programme 'has already completed genome sequencing of over 10,000 individuals and is progressing towards building one of the world's largest genomic databases.' The project was conceived to capture the extraordinary ethnic and regional genetic variation across the subcontinent — a diversity that homogeneous populations cannot replicate.

The National Digital Health Mission, also unveiled in 2020, had already laid the groundwork for integrating genomic data into the Ayushman Bharat Digital Mission, signalling that the current push is part of a multi-year architecture rather than a standalone announcement. The National Biotechnology Development Strategy similarly underpins the Science and Technology Ministry's parallel drive to deploy AI tools for clinical decision support and variant interpretation.

Dr. Singh highlighted artificial intelligence as a critical accelerant: 'AI is significantly reducing the time required to analyse complex medical data while enhancing the quality of clinical decision-making,' he said, linking faster data analysis directly to better patient outcomes.

Stakeholders and Impact

For Indian patients, the promise is treatment protocols calibrated to their specific genetic makeup rather than protocols derived from data collected predominantly in Western populations. For biomedical researchers, a large-scale, diverse national genomic database opens avenues for discovering disease associations that are invisible in smaller or less diverse datasets.

Dr. Singh underscored India's comparative advantage: 'Unlike countries with relatively homogeneous populations, India presents an extraordinary range of genetic variations and disease patterns across different regions, creating immense opportunities for biomedical research.' He argued this 'unique advantage enables India not only to address its own healthcare challenges but also to develop solutions that can benefit the global community.'

The minister explicitly tied these ambitions to Prime Minister Narendra Modi's diplomatic framing, invoking the concept of Vishwabandhu Bharat — India as a friend to the world — to argue that domestic R&D breakthroughs in affordable healthcare carry soft-power implications beyond the subcontinent.

What's Next

The Department of Biotechnology is expected to release its next progress report on the Genome India database scale-up, with attention focused on whether sequencing targets will be expanded beyond the current phase. Regulatory pathways for AI-enabled diagnostics remain an active area of policy development within the ministry. National Doctors Day on 1 July is likely to see further government communication reinforcing the precision medicine agenda as a tribute to the medical community. India's ability to translate its genomic database into actionable clinical protocols — and to share those findings affordably with lower-income countries — will be the real measure of whether the Vishwabandhu Bharat vision in healthcare moves from rhetoric to results.